Addiction, Opioid
Conditions
Brief summary
There are two study periods for the TCU JCOIN project. The primary aims of Study 1 (approved by the TCU IRB) are (1) to gather information from staff on the current treatment referral process within participating communities and (2) to learn about the existing interrelationships between medical and community behavioral health (CBH) providers. TCU IRB granted approval for Phase 1 on 11/07/19, approval number: 1920-60-AM1. Study 2 (under current review by the TCU IRB) includes recruitment across 18 community collaboration sites across 3 states; these communities will participate in the TCU Opioid-Treatment Linkage Model (O-TLM) protocol. The O-TLM is focused on best practices for improving screening, identifying and linking to MOUD providers, reducing stigma, and addressing other important factors that impact justice-involved individuals returning to their communities. Along with their agency records, information collected from justice-involved individuals within the target communities will be examined to assess O-TLM impact on improving public health and public safety outcomes. Furthermore, stakeholder staff across community organizations, including criminal justice and treatment agencies, will be asked to complete surveys on the O-TLM regarding its acceptability and adoption, as well as on best training strategies.
Interventions
BEHAVIORALTCU Opioid-Treatment Linkage Model (O-TLM)
The O-TLM is focused on best practices for improving screening, identifying and linking to MOUD providers, reducing stigma, and addressing other important factors that impact justice-involved individuals returning to their communities.
Sponsors
University of New Mexico
Loyola University
Texas Christian University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Intervention model description
Our design is a Hybrid Type 3 design with the primary aim to compare 2 implementation strategies, and a secondary aim to assess client-level outcomes associated with the trial; the design includes a cluster randomized parallel design with staggered starts
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* client level participant eligibility includes having a history of opioid use or at risk for opioid use; being released to a participating community while under supervision * staff level participant eligibility includes being a key member of a participating community and involved in the service assessment and referral process of justice-involved individuals.
Exclusion criteria
* no history of opioid use or being at risk of opioid use; not being released to a participating community. * staff level participant
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Public Health assessed by decrease in days and amount of illicit drug use, including opioids | 6 months and 12 months post-release | decreases in days and amount of illicit drug use, including opioids assessed through client interviews using the timeline follow-back method |
| Public Safety as assessed through reduction in rearrest rates | 6 months and 12 months post-release | reductions in rearrest rates measured through justice and department of pubic safety records |
| Increase in Access to Services | 6 months and 12 months post-release | referral rate increase as self-reported through client interviews and provided through justice records |
| Increase in Retention in Services | 6 months and 12 months post-release | appointments kept as self-reported through client interviews and provided through justice and provider records |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Systems Impact as assessed through improved intervention attitudes | 6 and 12 months post implementation start | staff attitudes of intervention acceptability as assessed through survey |
| Systems Impact as assessed through intervention cost | 6 and 12 months post implementation start | accumulated cost of intervention |
Countries
United States
Contacts
Primary ContactJennifer Becan, PhD
Outcome results
None listed